Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
50
currently held
Exits tracked
27
hand-checked
Sectors covered
1
across the portfolio
Countries covered
12
from every market
72 companies matching · Page 1 of 2
Myricx Bio
Myricx Bio
Abingworth Bioventures 8
United Kingdom
Exited
Sector
Healthcare / Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Owners
2
Exit
2026
PinCell
PinCell
Sofinnova Capital IX
Italy
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2019
Hold
6yr
Exit
2025
Calliditas
Calliditas
Sofinnova Crossover Fund I
Sweden
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2020
Hold
4yr
Exit
2024
VectivBio
Sofinnova Capital VIII
Switzerland
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2017
Hold
6yr
Exit
2023
Noema Pharma
Noema Pharma
Jeito I
Switzerland
Active
Sector
Healthcare / Biotech
InvestorJeito Capital
Entry
2020
Hold
3yr
Owners
2
ABIONYX Pharma
Sofinnova Capital VI
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2010
Hold
10yr
Exit
2020
Breath Therapeutics
Gimv Portfolio
Germany
Exited
Sector
Healthcare / Biotech
InvestorGimv
Entry
2016
Hold
3yr
Owners
2
Exit
2019
Hookipa Pharma
Sofinnova Capital IX
Austria
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2013
Hold
7yr
Owners
2
Noxxon Pharma
Sofinnova Capital VI
Germany
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
1998
Hold
20yr
Owners
2
Exit
2018
Ablynx NV
Sofinnova Capital VI
Belgium
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2008
Hold
10yr
Exit
2018
Lysogene
Sofinnova Capital VIII
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2015
Hold
3yr
Exit
2018
Delinia
Sofinnova Capital VIII
United Kingdom
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2016
Hold
1yr
Exit
2017
ObsEva
Sofinnova Capital VIII
Switzerland
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2015
Hold
2yr
Exit
2017
Ascendis Pharma
Sofinnova Capital VII
Denmark
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2012
Hold
3yr
Exit
2015
GlycoVaxyn
Sofinnova Capital VII
Switzerland
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2012
Hold
3yr
Exit
2015
DBV
Sofinnova Capital VI
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2010
Hold
4yr
Exit
2014
EOS
Sofinnova Capital VII
Italy
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2012
Hold
1yr
Exit
2013
Omthera Pharmaceuticals
Sofinnova Capital VI
United States
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2010
Hold
3yr
Exit
2013
Addex Therapeutics
Sofinnova Capital VI
Switzerland
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2008
Hold
4yr
Exit
2012
Movetis
Sofinnova Capital VI
Belgium
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2008
Hold
2yr
Exit
2010
Novexel
Sofinnova Capital VI
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2006
Hold
4yr
Exit
2010
PregLem
Sofinnova Capital VI
Switzerland
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2006
Hold
4yr
Exit
2010
Innate Pharma
Sofinnova Capital VI
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2000
Hold
6yr
Exit
2006
Genset
Sofinnova Capital VI
France
Exited
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
1989
Hold
13yr
Exit
2002
Genespire
Genespire
Indaco BIO
Italy
Active
Sector
Healthcare / Biotech
InvestorIndaco Venture Partners SGR
Entry
2020
Hold
6yr
Owners
4
iOmx Therapeutics
iOmx Therapeutics
MIG Fonds 16
Germany
Active
Sector
Healthcare / Biotech
InvestorMIG Capital
Entry
2016
Hold
10yr
Owners
4
Haya Therapeutics
Haya Therapeutics
Earlybird Health
Switzerland
Active
Sector
Healthcare / Biotech
InvestorEarlybird Venture Capital
Entry
2021
Hold
5yr
Owners
3
T-Therapeutics
T-Therapeutics
BGF
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorBGF
Entry
2023
Hold
3yr
Owners
3
Actithera
Actithera
Sofinnova Capital XI
France
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2025
Hold
1yr
Owners
2
Alia Therapeutics
Alia Therapeutics
Sofinnova Telethon
Italy
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
Owners
2
Forth Therapeutics
Forth Therapeutics
Old College Capital LP
Italy
Active
Sector
Healthcare / Biotech
InvestorOld College Capital
Entry
2023
Hold
3yr
Owners
2
Freya Biosciences
Freya Biosciences
Indaco BIO
Denmark
Active
Sector
Healthcare / Biotech
InvestorIndaco Venture Partners SGR
Entry
2023
Hold
3yr
Owners
2
MaxCyte
MaxCyte
Vitruvian Investment Partnership IV
United States
Active
Sector
Healthcare / Biotech
InvestorVitruvian Partners
Entry
2019
Hold
7yr
Owners
2
Mediar Therapeutics
Mediar Therapeutics
Sofinnova Capital X
United States
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
Owners
2
Mission Therapeutics
Mission Therapeutics
Rosetta Capital V
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorRosetta Capital
Entry
2019
Hold
7yr
Owners
2
Mozart Therapeutics
Mozart Therapeutics
Leaps by Bayer
United States
Active
Sector
Healthcare / Biotech
InvestorLeaps by Bayer
Entry
2021
Hold
5yr
Owners
2
Nuage Therapeutics
Nuage Therapeutics
Sabadell Asabys Health Innovation Investments II
Spain
Active
Sector
Healthcare / Biotech
InvestorAsabys Partners
Entry
2023
Hold
3yr
Owners
2
Signadori Bio
Signadori Bio
Invivo Ventures III
Italy
Active
Sector
Healthcare / Biotech
InvestorInvivo Partners
Entry
2025
Hold
1yr
Owners
2
Sitryx Therapeutics
Sitryx Therapeutics
Sofinnova Capital X
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2018
Hold
8yr
Owners
2
Borea Therapeutics
Borea Therapeutics
Sofinnova Telethon
Italy
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
Catamaran Bio
Catamaran Bio
Sofinnova Capital X
United States
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2022
Hold
4yr
Elevara Medicines
Elevara Medicines
Sofinnova Capital X
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2022
Hold
4yr
Enthera Pharmaceuticals
Enthera Pharmaceuticals
Sofinnova Capital X
Italy
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2022
Hold
4yr
Ermium
Ermium
Kurma Biofund III
France
Active
Sector
Healthcare / Biotech
InvestorEurazeo
Entry
2019
Hold
7yr
F2G
F2G
Sofinnova Crossover Fund I
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
Hemab Therapeutics
Hemab Therapeutics
Sofinnova Crossover Fund I
Denmark
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2020
Hold
6yr
Home Biosciences
Home Biosciences
Sofinnova Capital X
France
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2022
Hold
4yr
HotSpot Therapeutics
HotSpot Therapeutics
Sofinnova Capital IX
United States
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
Inspirna
Inspirna
Sofinnova Capital X
United States
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
Mironid
Mironid
Sofinnova Capital X
United Kingdom
Active
Sector
Healthcare / Biotech
InvestorSofinnova Partners
Entry
2021
Hold
5yr
Previous12Next